171 related articles for article (PubMed ID: 1982446)
1. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
Sherry RL; Baker GB; Coutts RT; Mousseau DD
J Neural Transm Suppl; 1990; 32():107-12. PubMed ID: 1982446
[TBL] [Abstract][Full Text] [Related]
2. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
Sherry RL; Baker GB; Coutts RT
Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
[No Abstract] [Full Text] [Related]
5. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
[TBL] [Abstract][Full Text] [Related]
6. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline.
Greenshaw AJ; Rao TS; Nazarali AJ; Baker GB; Coutts RT
Biol Psychiatry; 1989 Apr; 25(8):1014-20. PubMed ID: 2470425
[TBL] [Abstract][Full Text] [Related]
7. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine.
Baker GB; Hampson DR; Coutts RT; Micetich RG; Hall TW; Rao TS
J Neural Transm; 1986; 65(3-4):233-43. PubMed ID: 3711885
[TBL] [Abstract][Full Text] [Related]
9. Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine.
Fitzgerald DH; Tipton KF; Lyles GA
J Neural Transm Suppl; 1998; 52():259-64. PubMed ID: 9564625
[TBL] [Abstract][Full Text] [Related]
10. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitors: effects on tryptophan concentrations in rat brain.
Sherry-McKenna RL; Wong JT; Paetsch PR; Baker GB; Mousseau DD; McKenna KF; Coutts RT; Greenshaw AJ
J Neural Transm Suppl; 1994; 41():155-63. PubMed ID: 7931222
[TBL] [Abstract][Full Text] [Related]
12. Lithium alters the stereoselectivity of monoamine oxidase in rat brain.
Smith DF
J Neural Transm; 1989; 76(3):205-10. PubMed ID: 2732725
[TBL] [Abstract][Full Text] [Related]
13. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
Celada P; Artigas F
J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine.
Hampson DR; Baker GB; Coutts RT
Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
Kettler R; Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitory properties of milacemide in rats.
Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
[TBL] [Abstract][Full Text] [Related]
18. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
19. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
[TBL] [Abstract][Full Text] [Related]
20. Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants.
Baker GB; LeGatt DF; Coutts RT; Dewhurst WG
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):653-6. PubMed ID: 6531436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
